Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Key Points: Reduced prothrombin improves survival and ameliorates inflammation and end-organ damage without spontaneous bleeding in sickle cell mice. An individual procoagulant, prothrombin, represents a novel therapeutic target that can improve sickle cell disease outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 2×
“It is characterized by erythrocyte sickling, chronic hemolytic anemia, episodic acute vaso-occlusions, chronic systemic inflammation at baseline, and acute and chronic cumulative organ damage.(1-7) Therapeutic options to prevent organ pathologies are limited to chronic transfusions, hydroxyurea, or an allogeneic hemat…”
BackgroundCell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330 · cited 1×
“It is characterized by erythrocyte sickling, chronic hemolytic anemia, episodic acute vaso-occlusions, chronic systemic inflammation at baseline, and acute and chronic cumulative organ damage.(1-7) Therapeutic options to prevent organ pathologies are limited to chronic transfusions, hydroxyurea, or an allogeneic hemat…”
BackgroundPathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 2×
“It is characterized by erythrocyte sickling, chronic hemolytic anemia, episodic acute vaso-occlusions, chronic systemic inflammation at baseline, and acute and chronic cumulative organ damage.(1-7) Therapeutic options to prevent organ pathologies are limited to chronic transfusions, hydroxyurea, or an allogeneic hemat…”
BackgroundFlick, M. J., Du, X., Witte, D. P., Jiroušková, M., Soloviev, D. A., Busuttil, S. J., Plow, E. F., & Degen, J. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20741 · Cited by 450
Self-citationWood, B., Gibson, D., & Tait, J. (1996) · Blood · doi:10.1182/blood.v88.5.1873.1873 · Cited by 445
Extracellular hemin crisis triggers acute chest syndrome in sickle mice
Ghosh, S., Adisa, O. A., Chappa, P., Tan, F., Jackson, K. A., Archer, D. R., & Ofori-Acquah, S. F. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64578 · Cited by 282
Hsu, L. L., Champion, H. C., Campbell-Lee, S. A., Bivalacqua, T. J., Manci, E. A., Diwan, B. A., Schimel, D. M., Cochard, A. E., Wang, X., Schechter, A. N., et al. (2007) · Blood · doi:10.1182/blood-2006-08-039438 · Cited by 263
Brittenham, G., Schechter, A., & Noguchi, C. (1985) · Blood · doi:10.1182/blood.v65.1.183.183 · Cited by 197
Airway hyperreactivity in children with sickle cell disease
Leong, M. A., Dampier, C., Varlotta, L., & Allen, J. L. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70166-5 · Cited by 140 · cited 1×
“The latter is a feature of airway reactivity, another known association with SCD.(65-67) As anticipated, PHT and other associated pulmonary pathologies were absent in HbA chimeras.”
BackgroundHeparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Matsui, N. M., Varki, A., & Embury, S. H. (2002) · Blood · doi:10.1182/blood-2002-02-0626 · Cited by 123 · cited 1×
“Nevertheless, these studies have shown that some of the anticoagulant and antiplatelet agents can be safely given to patients with SCD without inordinate risk of bleeding.(45,82-89) Two placebocontrolled studies of acencoumarol and tinzaparin have been performed,(90,91) of which the large randomized placebo-controlled…”
Background
Cited by
Zhang, D., Xu, C., Manwani, D., & Frenette, P. S. (2016) · Blood · doi:10.1182/blood-2015-09-618538 · Cited by 413
“More recently, it has been reported that genetic deletion of circulating prothrombin alleviates multiorgan pathologies in SCD mice.(98) In addition, thrombospondin-1 can stimulate microparticle release from RBCs.”
BackgroundInflammation in sickle cell disease
Conran, N., & Belcher, J. D. (2018) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-189012 · Cited by 294
Maitra, P., Caughey, M., Robinson, L., Desai, P. C., Jones, S., Nouraie, M., Gladwin, M. T., Hinderliter, A., Cai, J., & Ataga, K. I. (2017) · Haematologica · doi:10.3324/haematol.2016.153791 · Cited by 137
Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology
Bakeer, N., James, J., Roy, S., Wansapura, J., Shanmukhappa, S. K., Lorenz, J. N., Osinska, H., Backer, K., Huby, A.-C., Shrestha, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600311113 · Cited by 79
“Over the ECG surveillance month, the mortality rate among the sickle mice was about 40%, consistent with the overall mortality in our Berk-SS mouse colony (56).”
ResultSelf-citation
Metadata
- Authors
- Arumugam, P. I., Mullins, E. S., Shanmukhappa, S. K., Monia, B. P., Loberg, A., Shaw, M. A., Rizvi, T., Wansapura, J., Degen, J. L., & Malik, P.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-10-08
- Volume
- 126
- Issue
- 15
- Pages
- 1844-1855
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2149786825
- Cited by
- 59
- References
- 10
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice. https://app.cochat.ai/papers/10.1182/blood-2015-01-625707
- The paper
- Arumugam, P. I., Mullins, E. S., Shanmukhappa, S. K., Monia, B. P., Loberg, A., Shaw, M. A., Rizvi, T., Wansapura, J., Degen, J. L., & Malik, P. (2015). Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice. Blood. https://doi.org/10.1182/blood-2015-01-625707
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.